“N-ras Gene Point Mutations in Brazilian Acute Myelogenous Leukemia Patients Correlate with a Poor Prognosiss”

Leukemia and Lymphoma

Volumn 24, Issue 42067, 1997, Pages 309-317

  de Melo, Mönica Barbosa ^a   Lorand Metze, Irene ^a   Lima, Carmen Silvia Passos ^a   Saad, Sara Terezinha Ohlala ^a   Costa, Fernando Ferreira ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

AML; mutations; N ras; Oncogene

Indexed keywords

DNA;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BRAZIL; CANCER GENETICS; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; GENE FREQUENCY; HUMAN; HUMAN CELL; MUTATION RATE; ONCOGENE RAS; POINT MUTATION; PRIORITY JOURNAL; PROGNOSIS;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BRAZIL; CONTINENTAL POPULATION GROUPS; DNA, NEOPLASM; EXONS; FEMALE; GENE FREQUENCY; GENES, RAS; HUMANS; LEUKEMIA, MYELOID; LIFE TABLES; MALE; MIDDLE AGED; POINT MUTATION; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0031053856     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428199709039018     Document Type: Article

References (48)

1. Barbacid M. ras genes. Ann. Rev, Biochem. 1987; 56: 779 – 827
2. Kastan M. B., Strauss L. C., Civin C. I. The role of hematopoietic growth factors and oncogenes in leukemogenesis. Am. J. Pediatr. Hematol. Oncol. 1989; 11: 249 – 267
3. McKenzie S. J. Diagnostic utility of oncogenes and their products in human cancer. Biochim. Biophys. Acta. 1991; 1072: 193 – 214
4. Haubruck H., McCormick F. ras p21: effects and regulation. Biochim. Biophys. Acta. 1991; 1072: 215 – 229
5. Barbacid M. ras oncogenes: their role in neoplasia. Eur. J. Clin. Inv. 1990; 20: 225 – 235
6. Chang E. H., Miller P. S., Cushman C., Devadas K., Piroilo K. F., Ts'o P. O., Yu Z. P. Antisense inhibition of ras p21 expression that is sensitive to a point mutation. Biochemistry 1991; 30: 8283 – 8286
7. Bos J. L., Toksoz D., Marshall C. J., Verlaan-de Vries M., Veeneman G. H., van der Eb A. J., van Boom J. H., Janssen J. W., Steenvoorden A. C. Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia. Nature 1985; 315: 726 – 730
8. Lubbert M., Mirro J., Jr., Miller C. W., Kahan J., Isaac G., Kitchingman C., Mertelsmann R., Herrman F., McCormick F., Koeffler H. P. N-ras gene point mutations in childhood acute lymphocytic leukemia correlate with a poor prognosis. Blood 1990; 75: 1163 – 1169
9. Janssen J. W. G., Steenvoorden A. C. M., Lyons J., Anger B., Böhlke J. U., Bos J. L., Seliger H., Bartram C. R. ras gene mutations in acute and chronic myelocitic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes. Proc. Natl. Acad. Sci. USA 1987; 84: 9228 – 9232
10. Radich J. P., Kopecky K. J., Willman C. L., Weick J., Head D., Appelbaun F., Collins S. J. N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance. Blood 1990; 76: 801 – 807
11. Neubauer A., Dodge R. K., George S. L., Davey F. R., Silver R. T., Schiffer C. A., Mayer R. J., Ball E. D., Wuster-Hill D., Bloomfield C. D., Liu E. T. Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia. Blood 1994; 83: 1603 – 1611
12. Padua R. A., Carter G., Hughes D., Gow J., Farr C., Oscier D., McCormick F., Jacobs A. ras mutations in myelodysplasia detected by amplification, oligonucleotide hybridization, and transformation. Leukemia 1988; 2: 503 – 510
13. Taylor J. A., Sandler D. P., Bloomfield C. D., Shore D. L., Ball E. D., Neubauer A., McIntyre O. R., Liu E. ras oncogene activation and occupational exposures in acute myeloid leukemia. J. Natl. Cancer Inst. 1992; 84: 1626 – 1632
14. Melo M. B., Sales T. S. I., Lorand-Metze I., Costa F. F. Rapid method for isolation of DNA from glass slide smears for PCR. Acta Haematol. 1992; 87: 214 – 215
15. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Proposals for classification of the acute leukaemia French-American-British (FAB) Cooperative Group. Br. J. Haematol. 1976; 33: 451458
16. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7): a report of the French-American-British Cooperative Group. Ann. Int. Med. 1985; 103: 460 – 462
17. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann. Int. Med. 1985; 103: 626 – 629
18. Yunis J. J. New Chromosome techniques in the study of human neoplasia. Human Pathol. 1981; 12: 540 – 549
19. Testa J. R., Rowley J. D. Chromosomes in leukemia and lymphoma with special emphasis on methodology. The leukemia cell, D. Catovsky. Churchill-Livingstone, Edinburg 1980; 184
20. ISNC. Guidelines for cancer cytogenetics, supplement to an International System for Human Cytogenetic Nomenclature, F. Mitelman. S. Karger, Basel 1991
21. Büchner T., Hiddeman W., Loffler G., Gassmann W., Maschmeyer G., Heit W., Hossfeld D., Weh H., Ludwig W. D., Thiel E., Nowrousian M., Aul C., Lengfelder E., Lathan B., Mainzer K., Urbanitz D., Emmerich B., Middelhoff G., Donhuijsen-Ant H. R., Hellriegel H. P., Heinecke A. Improved cure rate by very early intensification combined with prolonged maintenance chemotherapy in patients with acute myeloid leukemia: data from the AML Cooperative Group. Seminars Hematol. 1991; 28: 76 – 79
22. Wahlin A., Homsten P., Jonsson H. Remission rate and survival in acute myeloid leukemia: impact of selection and chemotherapy. Eur. J. Haematol. 1991; 46: 240 – 247
23. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning, a Laboratory Manual2nd ed. Cold Spring Harbor, New York 1989
24. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higushi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487 – 491
25. Costa F. F., Figueiredo M. S., Sonati M. F., Kimura E. M., Martins C. S. B. The IVS 1–110 and codon 39 beta thalassemia mutations in association with alpha tha12 (-37 Kb) and Hb Hasharon in a Brazilian patient. Hemoglobin 1992; 16: 525 – 528
26. Lyons J., Janssen J. W. G., Bartram C., Layton M., Mufti G. J. Mutation of N-ras and N-ras oncogenes in myelodysplastic syndromes. Blood 1988; 71: 1707 – 1712
27. Miranda S. R. P., Gonçalves M. S., Sonati M. F., Saad S. T. O., Costa F. F. Rapid identification of beta-globin strutural variants by sequencing the mRNA from peripheral blood retyculocytes. Bruz. J. Med. Biol. Rex 1993; 26: 1025 – 1030
28. Wilcoxon F. Individual comparison by ranking methods. Biometrics 1945; 1: 80 – 83
29. Mann H. B., Whitney D. R. On a test of whether one of two random variables is stochastically larger than the other. Ann. Muth. Statist. 1947; 18: 50 – 60
30. Fisher R. A. Statistical methods for research workers, Oliver, Boyd. Edinburgh. 1934
31. Gehan E. A. A generalized two sample Wilcoxon test for doubly-censored data. Biometrika 1965; 52: 650 – 653
32. Gehan E. A. A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 1965; 52: 203 – 223
33. Smit V. T. H. B. M., Boot A. J. M., Smits A. M. M., Fleuren G. J., Cornelisse C. J., Bos J. L. K-ras codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res. 1988; 16: 7773 – 7783
34. Rodenhuis S., Slebos R. J., Boot A. J. M., Evers S. G., Mooi W. J., Wagenaar S. S., van Bodegon P. C., Bos J. L. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res. 1988; 48: 5738 – 5741
35. Suzuki Y., Orita M., Shiraishi M., Hayashi K., Sekiya T. Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 1990; 5: 1037 – 1043
36. Lemoine N. R., Mayall E. S., Wyllie F. S., Farr C. J., Hughes D., Padua R. A., Thurston V., Williams E. D., Wynford-Thomas D. Activated ras oncogenes in human thyroid cancers. Cancer Res. 1988; 48: 4459 – 4463
37. Bos J. L., Fearon E. R., Hamilton S. R., Verlaan-de Vries M., van Boom J. H., van der EB A. J., Vogelstein B. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987; 327: 293 – 297
38. Forrester K., Almoguera C., Han K., Grizzle W. E., Perucho M. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 1987; 327: 298 – 303
39. Senn H. P., Tran-Thang C., Wodnar-Filipowicz A., Jiricny J., Fopp M., Gratwohl A., Signer E., Weber W., Moroni C. Mutation analysis of the N-ras proto-oncogene in active and remission phase of human acute leukemias. Int. J. Cancer 1988; 41: 59 – 64
40. Farr C., Gill R., Katz F., Gibbons B., Marshall C. Analysis of ras gene mutations in childhood myeloid leukaemia. Br. J. Haematol. 1991; 77: 323 – 327
41. Ahuja H. G., Foti A., Bar-Eli M., Cline M. J. The pattern of mutational involvement of ras genes in human hematologic malignancies determined by DNA amplification and direct sequencing. Blood 1990; 75: 1684 – 1690
42. Chin I. Y., Koh C., Bosco J. L. ras gene mutations in Malaysian leukemia patients. Acta Haematol. 1992; 87: 107 – 108
43. van Mansfeld A. D. M., Bos J. L. PCR-based approaches for detection of mutated ras genes. PCR Methods and Applications 1992; 1: 211 – 216
44. Bos J. L., Verlaan-de Vries M., van der Eb A. J., Janssen J. W. G., Delwel R., Lowenberg B., Colly L. P. Mutations in N-ras predominate in acute myeloid leukemia. Blood 1987; 69: 1237 – 1241
45. Browett P. J., Norton J. D. Analysis of ras gene mutations and methylation state in human leukemias. Oncogene 1989; 4: 1029 – 1036
46. Lorand I. G. H., Souza C. A., Costa F. F. Hematological toxicity associated with agricultural chemicals. Lancet 1984; 1: 404
47. Fax C. J., Saiki R. K., Erlich H. A., McCormick F., Marshall C. J. Analysis of ras gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes. Proc. Natl. Acad. Sci. USA 1988; 85: 1629 – 1633
48. Bartram C. R., Ludwig W. D., Hiddeman W., Lyons J., Buschle M., Ritter J., Harbott J., Frohlic A., Janssen J. W. Acute myeloid leukemia: analysis of ras gene mutations and clonality defined by polymorphic X-linked loci. Leukemia. 1989; 3: 247 – 256